Christopher P Phenix (Chris P Phenix)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Dendritic Cells

Photodynamic Therapy

Molecular Dynamics

Top Venues

Molecular pharmaceutics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabet Jakova, Omozojie P Aigbogun, Mohamed Taha Moutaoufik, Kevin J H Allen, Omer Munir, Devin Brown, Changiz Taghibiglou, Mohan Babu, Christopher P Phenix, Ed S Krol, Francisco S Cayabyab
The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors. International journal of molecular sciences 25 (17) (2024)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics (2023)
Brenda Huska, Sarah Niccoli, Christopher P Phenix, Simon J Lees
Leucine Potentiates Glucose-mediated 18F-FDG Uptake in Brown Adipose Tissue via β-Adrenergic Activation. Biomedicines 8 (6) (2020)